CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

Cantarero, I - Medical Cannabis Research Engine

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Cantarero, I

OPENALEX: A5053541710↗ORCID: 0000-0001-9047-192X↗

Affiliations

Organizations

Hospital Universitario Reina Sofíaauthorship · ES Instituto Maimónides de Investigación Biomédica de Córdobaauthorship · ES University of Córdobaauthorship · ES

Public evidence

2 connected articles

VCE-003.2, a novel cannabigerol derivative, enhances neuronal progenitor cell survival and alleviates symptomatology in murine models of Huntington's disease.2016 · Europe PMC A cannabigerol derivative suppresses immune responses and protects mice from experimental autoimmune encephalomyelitis.2014 · Europe PMC

Matched by exact identifiers only. Profile data: ORCID. Last retrieved 23/08/2026.